Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

Study suggests repeated ketamine doses significantly improves PTSD symptoms

Staff Writer
Staff Writer 1 year ago
Updated 2021/05/12 at 6:20 PM
Share
SHARE

In America, nearly 4 percent of adults are affected by post-traumatic stress disorder (PTSD). While pharmacotherapeutic options are limited with regards to this condition, new research in the American Journal of Psychiatry provides insight into the use of ketamine for treating symptoms of PTSD.

According to researchers from the Icahn School of Medicine at Mount Sinai Hospital, repeated doses via intravenous of ketamine may significantly improve PTSD symptoms among adults.

During the study, ketamine was administered to 30 adult participants who met the criteria for chronic PTSD. Each participant received either six infusions of ketamine or midazolam, another form of anesthetic with no significant psychoactive properties.

Assessments were conducted on a weekly basis, measuring side effects arising from the treatment.

By the study’s conclusion, the results were clear: repeated administration of ketamine was suggested to be beneficial for reducing symptom severity of PTSD rapidly, with the effects lasting for several weeks.

No serious adverse events were documented throughout the study’s lifespan of administering ketamine infusions for PTSD patients.

“This randomized controlled trial provides the first evidence of efficacy of repeated ketamine infusions in reducing symptom severity in individuals with chronic PTSD,” the findings, as authored by Adriana Feder and her colleagues, state.

“Further studies are warranted to understand ketamine’s full potential as a treatment for chronic PTSD.”

Photo: iStockPhoto

You Might Also Like

ICD-11 lists complex post-traumatic stress disorder as a new condition

Study shows the likely outcomes of very preterm born children

Researchers find that stress accelerates immune aging

Study finds heavy drinkers are significantly more likely to smoke

Researchers suggest menthol cigarettes may raise the possibility of youth smoking and addiction

TAGGED: ketamine, ptsd
Staff Writer January 11, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Gut-brain interactions may help explain the correlation between dietary fiber and depressive traits
Next Article New research uncovers the role of gut microbes in anorexia nervosa

Recommended

Clinical

ICD-11 lists complex post-traumatic stress disorder as a new condition

1 Min Read
Health

Study shows the likely outcomes of very preterm born children

1 Min Read
Health

Researchers find that stress accelerates immune aging

2 Min Read
Health

Study finds heavy drinkers are significantly more likely to smoke

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?